School of Medicine
Showing 1-81 of 81 Results
-
Andrei Iagaru
Professor of Radiology (Nuclear Medicine)
Current Research and Scholarly InterestsCurrent research projects include:
1) PET/MRI and PET/CT for Early Cancer Detection
2) Targeted Radionuclide Therapy
3) Clinical Translation of Novel PET Radiopharmaceuticals; -
David Iberri
Clinical Assistant Professor, Medicine - Hematology
BioDr. Iberri is a hematologist who specializes in the treatment of multiple myeloma, Waldenström macroglobulinemia, and other blood and bone marrow disorders. He is actively involved in clinical research evaluating novel agents in hematologic malignancies. His research interests include the development and application of biomarkers to select patients most likely to benefit from therapy, and in the development of blood tests to reduce the need for bone marrow biopsies in myeloma disease monitoring.
-
Kenzo Ichimura
Postdoctoral Scholar, Pulmonary and Critical Care Medicine
BioMy long-term goal as a physician-scientist is to develop therapeutic strategies for right heart failure by elucidating its pathophysiology.
I graduated from Kyushu University, School of Medicine in Fukuoka, Japan in 2008. Following a residency program at Aso Iizuka Hospital, I finished fellowship in Emergency Medicine (1 year) and Cardiovascular Medicine (2 years). My clinical expertise is general cardiology, cardiac catheterization, echocardiography, and cardiac critical care.
After my clinical training, I started my research career working towards a Ph.D. under the mentorship of Dr. Kensuke Egashira. During my Ph.D., I published two papers focusing on the development of novel therapeutics for acute myocardial infarction and pulmonary arterial hypertension. Through this research experience, I developed skills in modeling and assessing cardiovascular disease in both small (rodents) and large animals (pigs)
In 2017, I was appointed as an Assistant Professor and attending physician in the Department of Emergency and Critical Care Medicine at Kyushu University Hospital. During this period, I learned that right heart failure was one of the most devastating conditions with no treatment options in patients with pulmonary hypertension, congenital heart disease, and patients on long-term mechanical ventricular assist devices. I also continued my research with a research grant funded by the Japanese Society for the Promotion of Science.
In 2019, I decided to further expand my research field into right heart failure and joined Dr. Edda Spiekerkoetter’s lab at Stanford University as a postdoctoral fellow. I am currently focusing on the role of BMPR2 in the cardiomyocytes, the structural changes in the right ventricle under pressure overload, and the development of right ventricle-targeting therapy in pulmonary hypertension. -
Juliana Idoyaga
Assistant Professor of Microbiology and Immunology
Current Research and Scholarly InterestsThe Idoyaga Lab is focused on the function and biology of dendritic cells, which are specialized antigen-presenting cells that initiate and modulate our body’s immune responses. Considering their importance in orchestrating the quality and quantity of immune responses, dendritic cells are an indisputable target for vaccines and therapies.
Dendritic cells are not one cell type, but a network of cells comprised of many subsets or subpopulations with distinct developmental pathways and tissue localization. It is becoming apparent that each dendritic cell subset is different in its capacity to induce and modulate specific types of immune responses; however, there is still a lack of resolution and deep understanding of dendritic cell subset functional specialization. This gap in knowledge is an impediment for the rational design of immune interventions. Our research program focuses on advancing our understanding of mouse and human dendritic cell subsets, revealing their endowed capacity to induce distinct types of immune responses, and designing novel strategies to exploit them for vaccines and therapies. -
Hirotaka Ieki
Postdoctoral Scholar, Genetics
BioCardiologist in Japan.
Research interest: precision medicine in cardiovascular disease. Genomics, Exposomics. -
Irogue I Igbinosa
Instructor, Obstetrics & Gynecology - Maternal Fetal Medicine
Masters Student in Epidemiology and Clinical Research, admitted Autumn 2022BioIrogue Igbinosa, MD is a Maternal-Fetal Medicine fellow at Stanford University. She graduated from the University of Houston and earned her medical degree at Baylor College of Medicine. She subsequently completed her residency in Obstetrics and Gynecology Residency at Louisiana State University School of Medicine Baton Rouge. After residency, she was an AAMC-CDC Public Health Policy Fellow able to serve in the CDC Emergency Operations Center and contribute to research for health care providers regarding the management of the Zika virus in pregnant persons. Dr. Igbinosa's current research interests include severe maternal morbidity and mortality, health disparities and equity, anemia in pregnancy, infectious diseases, and clinical trials.
-
Francie Igboabuchi
Life Science Rsch Prof 1, Stem Cell Bio Regenerative Med Institute
Current Role at StanfordLife Science Research Professional I
-
Debra M. Ikeda, M.D.
Professor of Radiology (Breast Imaging), Emerita
Current Research and Scholarly InterestsMy research interests are mammography positioning, tomosynthesis (DBT) cancer detection and diagnosis, MRI, DWI, MRI-guided breast biopsy, breast cancer recurrence, tattoo/ fiducial/wire localization of axillary lymph nodes, breast cancer and FDG PET-CT imaging, artifical intelligence/deep learning, breast density, density notification legislation, COVID-19 effects on Breast Imaging Centers and personnel
-
Gentaro Ikeda
Instructor, Medicine - Cardiovascular Medicine
BioDr. Ikeda is a physician-scientist who develops innovative diagnostic and therapeutic modalities for patients with cardiovascular disease. Based on his clinical experience as a cardiologist, he has become aware of major clinical shortcomings, specifically in the current pharmaceutical therapies for myocardial infarction (MI) and chronic heart failure (HF). Some evidence-based drug therapies, including β-blockers, ivabradine, and renin-angiotensin-aldosterone antagonists are difficult to apply to critical patients due to adverse side effects. Drugs that have shown efficacy in basic animal experiments have failed to show significant benefits in clinical trials. To address these problems, he moved to academia to conduct translational research. During his graduate training in the Egashira Lab, he focused on drug delivery systems (DDS) that target mitochondria in animal models of MI. He obtained advanced skills in molecular biology, mitochondrial bioenergetics, and animal surgery. He realized the importance of translational research and the great potential of DDS to overcome many clinical problems. He developed nanoparticle-mediated DDS containing cyclosporine for the treatment of patients with MI. He published a first-author paper and received academic awards for his novel science. Since becoming a postdoctoral fellow in the Yang Lab, he has continued to build upon his previous training in translational research. He is currently developing an innovative therapy, namely, extracellular vesicles-mediated mitochondrial transfer for mitochondria-related diseases such as heart failure and mitochondrial disease.
-
Fumiaki Ikeno
Program Director (U.S) Japan Biodesign, Stanford Biodesign, Medicine - Med/Cardiovascular Medicine
BioProgram Director (U.S) Japan Biodesign, Stanford Biodesign
Researcher Cardiovascular Medicine, Stanford University
Faculty of Japan Reach, CARE (Center for Asian Health Research and Education) , Stanford University
Co-Director of Asia, SPARK Global, Stanford SPARK , Stanford University
Dr. Ikeno is a Researcher, Cardiovascular Medicine, Stanford University. In this role, he is responsible for pre clinical studies including GLP for medical devices and also regenerative medicines for cardiovascular diseases. Currently, he is devoting himself to the international regulatory project between Japan and the United States, also known as "Harmonization by Doing", whose focus is to collaborate with regulatory agencies such as FDA, PMDA/MHLW, academia and industries for improving the regulatory process in the 2 largest medtech markets. Dr. Ikeno also devoted himself to found Japan biodesign program which is a collaborative program with University of Tokyo, Osaka University, Tohoku University, Japan Federation Medical Device Association, Ministry of Education Japan and Stanford biodesign program. Currently, Dr. Ikeno serves as the Program Director (US) for Japan Biodesign. Dr. Ikeno is co-founder and board member of US-Japan MedTech Frontier which is a non-profit cooperate to make a trans-pacific eco-system of medical device between Japan and USA.
After 9 years clinical practice as an interventional cardiologist and Family Doctor in rural areas of Japan, Dr. Ikeno came to Stanford as a Researcher and completed his Biodesign Certificate Program. Being part of the ecosystem in Silicon Valley, Dr. Ikeno participated in more than 200 medtech projects and 50 GLP studies as well as in the analysis of clinical trials for cardiovascular medicine (BARI2D, FAME, ReOPEN etc). His other academic consortium projects include Peripheral Academic Research Consortium, Global Consensus Working Group of Optical Coherence Tomography, and Japan-US consensus document for the treatment of critical limb ischemia.
Over the last decade, Dr. Ikeno has served as an advisor for medical device industries and currently serves as a chief medical officer of an incubation fund specific for medtech (Medventure Partners, Inc, Tokyo) as a spin-off from Innovation Network Corporation of Japan (INCJ) that is the largest government and private partnership fund in Japan. He is also serving as a chair of cardiovascular working group of APAN (Asian Pacific Advanced Network) that contributes the remote education, research activities, and tele-health using a specialized internet network. Dr.Ikeno is also serving as consulting faculty/lecturer roles in several universities in Japan including University of Tokyo, Osaka University, Tsukuba University etc. Dr. Ikeno has authored over 70 peer reviewed publications and textbooks and has been invited to lecture at international medical conferences. Dr. Ikeno is a council member of U.S.- Japan Council which is a non-profit organization by Japanese American. He is serving as a mentor for START-X MED which is an accelerating program for Stanford related entrepreneurs in medical fields.
Contact Information
Falk CVRC CV007
300 Pasteur Drive
Palo Alto, CA 94305-5406 -
Jennifer Ikle
Adjunct Clinical Assistant Professor, Pediatrics - Endocrinology and Diabetes
Current Research and Scholarly InterestsJen is interested in the genetic factors that lead to abnormal beta-cell function and insulin secretion, causing disorders such as hyperinsulinism and neonatal diabetes. Jen’s current research focus is the use of zebrafish models, combined with genetics and genomics, to understand cellular and molecular mechanisms of glucose metabolism and elucidate previously unknown players involved in the regulation of insulin secretion.
-
iva sikirica ilic
Adjunct Clinical Instructor, Educational Programs and Services (EPS)
BioIva Ilic, MD, is a board certified family physician with extensive experience as a hospitalist. She has a special interest in women's health, small office procedures and preventative care.
In her spare time, she hikes with her husband, and plays the piano. -
Daniel Imler
Clinical Associate Professor, Emergency Medicine
Clinical Associate Professor, PediatricsCurrent Research and Scholarly InterestsI am interested in understanding the impact of smart, agile clinical pathways to drive behavior change among providers.
-
Hiroyuki Inoue
Postdoctoral Scholar, Cardiovascular Medicine
BioDr. Inoue is a physician-scientist who is enthusiastic about bridging research findings and clinical practice.
- a board certified cardiologist with 10+ years clinical experience
- experience in 400+ cases as a main operator in percutaneous coronary intervention, catheter ablation, and cardiac device implantation
- research expertise primarily in iPSCs, genome editing, and regenerative medicine
Dr. Inoue joined the Yang lab in 2022. His research aim is the development of novel regenerative therapeutics for heart failure. -
Alexander Ioannidis
Instructor, Biomedical Data Science
Adjunct Professor, Institute for Computational and Mathematical Engineering (ICME)BioDr. Alexander Ioannidis is an Adjunct Professor in Computational and Mathematical Engineering, where he teaches machine learning and data science, and a researcher and Instructor in the Department of Biomedical Data Science. He earned his Ph.D. from Stanford University in Computational and Mathematical Engineering together with an M.S. in Management Science and Engineering (Optimization). He graduated summa cum laude from Harvard University in Chemistry and Physics and earned an M.Phil at the University of Cambridge from the Department of Applied Math and Theoretical Physics in Computational Biology. As a current researcher in the Stanford School of Medicine, Department of Biomedical Data Science his work focuses on the design of algorithms and application of computational methods for problems in genomics, clinical data science, and precision health with a particular focus on underrepresented populations in Oceania and Latin America.
-
John P.A. Ioannidis
Professor of Medicine (Stanford Prevention Research), of Epidemiology and Population Health and by courtesy, of Statistics and of Biomedical Data Science
Current Research and Scholarly InterestsMeta-research
Evidence-based medicine
Clinical and molecular epidemiology
Human genome epidemiology
Research design
Reporting of research
Empirical evaluation of bias in research
Randomized trials
Statistical methods and modeling
Meta-analysis and large-scale evidence
Prognosis, predictive, personalized, precision medicine and health
Sociology of science -
Eric Ip
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsMy research interests include the use and abuse of anabolic steroids and other performance enhancing/cognitive enhancing drugs.
-
Wui Ip, MD
Clinical Assistant Professor, Pediatrics
BioWui Ip, MD is a pediatrician and physician informaticist. He is interested in applying machine learning to support clinical decision making and improve patient care.
-
Behzad Iravani
Postdoctoral Scholar, Neurology and Neurological Sciences
BioI received my PhD in medicine from Karolinska Institutet, Sweden. My main research interest concerns accurate function mapping of the human frontal lobe, specially the medial and orbital parts where the non-invasive methods lose accuracy. Ultimately my research strives to improve mental health using combination of functional mapping and direct cortical stimulation.
-
Cynthia Irvine
Associate Dean, Office of Medical Education, School of Medicine - Student Affairs
Current Role at StanfordAssociate Dean, Office of Medical Education (MD Program)
-
Asef Islam
Masters Student in Biomedical Informatics, admitted Winter 2023
Masters Student in Computer Science, admitted Autumn 2022Current Research and Scholarly InterestsAI in medicine and other fields, particularly ML and CV techniques
-
Steven S Isono
Clinical Professor, Orthopaedic Surgery
BioDr. Steven Isono is an Orthopaedic Surgeon specializing in Sports Medicine as well as surgery of the knee and shoulder. He is Board Certified by the American Board of Orthopaedic Surgery in both Orthopaedic Surgery and in Sports Medicine with a Certificate of Added Qualification in Sports Medicine.
Dr. Isono grew up in the East Bay and graduated as the Valedictorian of Oakland High School during which he participated in Basketball, Baseball, Track and Field with All-State Honors in Gymnastics. He received a BA with Honors in Biochemistry from Harvard University in Cambridge, Massachusetts and wrote his Research Thesis on Erythrocyte Abnormalities in Sickle Cell Anemia. He then received his MD from Northwestern University Medical School in Chicago, Illinois and also performed research on Liver Hepatomas during medical school. His Internship in Plastic and Reconstructive Surgery and Residency in Orthopaedic Surgery were both completed at Stanford with additional training in Microsurgery in Japan at the Kyoto University Hospital and the Tokyo Metropolitan Hospital.
He is serving as Team Physician and Consultant for the United States Olympic and Paralympic Committee (USOPSC) for Men’s Swimming, Triathlon, Judo, Taekwondo, Track and Field, Men’s Rowing, and Boxing), the National Football League Players Association (NFLPA), the Oakland Panthers (Professional Indoor Football League), and Laney College. He was Team Physician for the Golden State Warriors of the National Basketball Association (NBA) for many years and completed this role in 2019. He is also a consultant for the Special Olympics, Ironman World Triathlon Championships, Dew Tour of Action Sports, and Association of Volleyball Professionals.
In addition to covering numerous National and International World Championship competitions, he has served as the Orthopedic Surgeon for TEAM USA for the 2015 XVII Pan American Games in Toronto, Canada, the 2016 XXXI Summer Olympic Games in Rio de Janeiro, Brazil, and 2018 Youth Olympic Games in Buenos Aries, Argentina as well as the 2019 XVIII Pan American Games in Lima, Peru. Dr. Isono was appointed the TEAM USA Head Team Physician at the 2021 XXXII Summer Olympic Games in Tokyo, Japan in July 2021 and the 2022 XXIV Winter Olympic Games in Beijing, China.
Dr. Isono also is a founder of a Non-Profit organization called the One Nation Project located in West Oakland. This program uses sports as an avenue to mentor kids-at-risk and involves kids from lower school through high school. Of his “first class” of kids, 10 of 11 kids graduated high school and college with a few of his “kids” becoming an Astrophysicist, a Financial Consultant, a Deputy Sheriff, and an Attorney. He is the co-founder of a second Non-Profit organization called Civic Assets which is a program for assisting Veterans affected with Post-Traumatic Stress Disorder (PTSD) and Traumatic Brain Injuries (TBI) transition and assimilate into society.
Dr. Isono is a member of the American Academy of Orthopaedic Surgeons, American Board of Orthopaedic Surgery, American Orthopaedic Society of Sports Medicine, Olympic Sports Medicine Society, Arthroscopy Association of North America, California Orthopaedic Association, Western Orthopaedic Association, NBA Team Physicians Society, and the American College of Sports Medicine. He also holds the position of an Expert Medical Reviewer for the Medical Board of California.
Among his many honors, Dr. Isono has earned the “Top Doctors in Sports Medicine” award in the California Magazine, Oakland Magazine, and Bay Area Consumer’s Checkbook, the Patients’ Choice Award for California’s Favorite Physicians, and designated among “America’s Top Orthopedists” and "Sports Medicine Physicians" by Consumer’s Research Council of America. -
Haruka Itakura, MD, PhD
Assistant Professor of Medicine (Oncology)
BioDr. Itakura is an Assistant Professor of Medicine (Oncology) in the Stanford University School of Medicine and practicing oncologist at the Stanford Cancer Center with background in biomedical informatics. She is a physician-scientist whose research mission is to drive medical advances at the intersection of cancer and data science research. Specifically, she aims to innovate state-of-the-art technologies to extract clinically useful knowledge from heterogeneous multi-scale biomedical data to improve diagnostics and therapeutics in cancer. She is a board-certified hematologist-oncologist and informaticist with specialized training in basic science, health services, and translational research. Her clinical background in oncology and PhD training in Biomedical Informatics position her to develop and apply data science methodologies on heterogeneous, multi-scale cancer data to extract actionable knowledge that can improve patient outcomes. Her ongoing research to develop and apply cutting-edge knowledge and skills to pioneer new robust methodologies for analyzing cancer big data is being supported by an NIH K01 Career Development Award in Biomedical Big Data Science. Her research focuses on developing and applying machine learning frameworks and radiogenomic approaches for the integrative analysis of heterogeneous, multi-scale data to accelerate discoveries in cancer diagnostics and therapeutics. Projects include prediction modeling of survival and treatment response, biomarker discovery, cancer subtype discovery, and identification of new therapeutic targets.
-
Michael Iv
Clinical Associate Professor, Radiology
Current Research and Scholarly InterestsMy clinical and research interests include brain tumor and vascular imaging in both the adult and pediatric populations, incorporating advanced MR imaging techniques and analyses using qualitative and quantitative methods.
-
Rebecca Ivancie
Clinical Associate Professor, Pediatrics
Current Research and Scholarly InterestsMedical Education Projects
- PHM Fellows and their training in Community Pediatric Hospital Medicine
Clinical Research: Using PHIS database to study MIS-C and Kawasaki disease -
Sarah Izabel
Ph.D. Student in Neurosciences, admitted Summer 2022
BioSarah was born and raised in Brazil where she attended law school before moving to the United States and shifting her interest to Neuroscience. She completed majors in Biology and Psychology at Virginia Commonwealth University (VCU) in 2020. At VCU, Sarah was part of the NIH-IMSD program and worked on uncovering mechanisms of axonal pathology in the lab of Dr. Jeff Dupree. She also worked on identifying the effects of income insecurity on decision-making in the lab of Dr. James Bjork. After graduating, Sarah worked at NIH as a UGSP Research Fellow and characterized a progranulin knockout mouse model in the lab of Dr. Alan Koretsky. She started her clinical work at NIH in the lab of Dr. Vijay Ramchandani where she worked to improve the diagnosis of alcohol use disorder. At Stanford, Sarah is interested in treating and managing neuropsychiatric disorders and increasing the representation of socially marginalized communities in research studies. When not in the lab Sarah enjoys reading, advocating for anti-poverty legislation, and hanging out with her son.
